Inference Investigation

Claim investigated: HPSP does not appear in SEC filings, indicating it is likely not a publicly traded company in the United States or has not filed required securities disclosures Entity: HPSP Original confidence: inferential Result: STRENGTHENED → SECONDARY

Assessment

The inferential claim is methodologically sound and can be elevated to secondary confidence. Given the established facts confirming HPSP is a Korean company (KOSDAQ: 403870), the absence from SEC filings is expected and correctly reasoned. However, the claim misses a critical regulatory pathway: if Crescendo Equity Partners operates SEC-registered funds, HPSP would appear in required foreign holdings disclosures.

Reasoning: The claim's core logic is validated by established facts showing HPSP is Korean-domiciled (KOSDAQ listing). SEC filing absence is expected for foreign companies without US operations or listings. The inference correctly identifies the jurisdictional mismatch but overlooks potential indirect SEC visibility through US investor disclosures.

Underreported Angles

• Bureau of Industry and Security export control documentation - Korean semiconductor equipment manufacturers require export licenses under ECCN 3B001, creating regulatory footprints not captured in standard SEC/USASpending searches
• Crescendo Equity Partners' SEC registration status remains completely unverified despite holding 39.42% of HPSP - this is the primary pathway for any US regulatory visibility
• CHIPS Act supplier disclosure requirements may classify Korean equipment manufacturer relationships as business confidential information under 15 CFR 7.12, explaining absence from public procurement records
• Korean DART system mandatory disclosures would contain definitive verification of all business metrics claims (639% return, 'world's only manufacturer' status) that remain completely unverified

Public Records to Check

• SEC EDGAR: Crescendo Equity Partners Form ADV filings and foreign holdings schedules Would confirm whether Crescendo's US funds must disclose the 39.42% HPSP stake, representing the primary pathway for SEC visibility

• other: Korea DART system: HPSP (403870) mandatory corporate disclosures 2022-2024 Primary source verification of all business metrics claims including 639% return and 'world's only manufacturer' status

• other: BIS export control license database: Korean semiconductor equipment exports to US ECCN 3B001 requirements could create regulatory documentation for Korean HPSP equipment sales to US semiconductor facilities

• other: USPTO/EPO patent databases: IPC codes H01L21/324 (semiconductor annealing) high-pressure hydrogen processes Only systematic method to verify 'world's only manufacturer' claims for high-pressure hydrogen annealing equipment

Significance

SIGNIFICANT — This represents the first methodologically sound regulatory analysis in the investigation, correctly identifying jurisdictional boundaries and potential indirect disclosure pathways. It provides the foundation for pivoting to appropriate Korean regulatory systems and SEC fund disclosures rather than continuing failed US corporate database searches.